Cascade Metrix


Cascade Metrix (CMX) is a medical technology company innovating in critical care with the AutoPlexer, an automated multiplex analyzer designed to revolutionize bedside testing of critical blood parameters. The company focuses on early diagnosis and treatment of sepsis and glycemic management, aiming to improve patient outcomes and reduce healthcare costs. They have completed prototypical development and preclinical validation, and are seeking investment and partnerships to advance their solutions.

Industries

health-care
hospital-650c
medical
medical-device

Nr. of Employees

small (1-50)

Cascade Metrix

11650 Olio Road, Suite 1000-110, Fishers, IN 46037-7619 USA


Products

Automated multiplex ex-vivo blood analyzer (prototype)

A prototype platform that automatically withdraws small volumes of whole blood from a patient vascular line, measures multiple analytes (glucose, lactate, hemoglobin, oxygen saturation) using integrated sensors, and reinfuses the sampled blood in a closed-loop process to avoid blood loss.


Services

Design and conduct of preclinical studies in large-animal models using central venous catheters, tethered device setups, infusion protocols, and paired reference measurements to validate automated sampling and sensing performance.

Partnerships for integrating external electrochemical sensors and other sensing modalities into an automated sampling platform and for coordinating prototype implementation with sensor suppliers and test sites.

Expertise Areas

  • Automated blood sampling
  • Multiplex point-of-care testing
  • Preclinical study execution
  • Microfluidic sample handling
  • Show More (5)

Key Technologies

  • Microfluidics
  • Electrochemical sensing
  • Flow-through sensors
  • Automated calibration routines
  • Show More (6)

News & Updates

Cascade Metrix completes the prototype development and preclinical validation of an automated multiplex analyzer (AutoPlexer) to support early diagnosis and treatment of sepsis.

Cascade Metrix has received a Notice of Intent to fund its SBIR Phase I Application from NIGMS.

Cascade Metrix was invited to participate in the Startup Company Showcase at the Diabetes Technology Meeting 2018!

Cascade Metrix conducted a 3-day pilot study on two pigs in partnership with Purdue University’s Pharmacology Testing Facility.

Cascade Metrix released preliminary results from ongoing studies in pig and rat models.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.